Login Start for Free

My Subscriptions My Account My Orders Log Out

Overview
Financial Statements
KPIs & Operating Metrics
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Payables Prepaid Assets Receivables - Other Retained Earnings Shareholder's Equity Total Current Liabilities Total Liabilities

Cash Flow Statement

Beginning Cash Balance Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Exchange Rate Effect Free Cash Flow Net Cash Flow Net Debt Issuances and Repayments Share-based Compensation

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Market Capitalization Price Price to Book Price to Earnings Price to Sales

Growth Metrics

Assets Growth (1y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash from Operations (QoQ)Cash from Operations Growth (1y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Gross Profit (QoQ)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Share-based Compensation (QoQ)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)

Income Statement

EPS (Basic)Gross Profit Operating Expenses Other Non Operating Income Profit After Tax Research & Development Selling, General & Administrative Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

EBIAT Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Shares Issued Wages, Salaries and Other

Ratios

Assets Average Enterprise Value Equity Average Equity Ratio Invested Capital

Bright Minds Biosciences (DRUG) Profit After Tax Growth (1y): 2021

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount